Skip to main content
An official website of the United States government
Email

CARE Regulatory Program

Monique Pond, PhD

Contact Monique Pond to learn more about this program.

Apply to the 2023 CARE Program.

The CARE program is an interagency collaboration between the National Cancer Institute (NCI) and Food and Drug Administration (FDA).  The goal of the program is to connect small businesses with the FDA and support communications during early stage product development.

Eligibility is open to NCI SBIR/STTR-funded small businesses that are developing potential technologies under the regulatory authority of FDA, including the Center for Biologics Evaluation and Research, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health.  In addition, the program is open to NHLBI SBIR/STTR-funded small businesses that are developing potential technologies under the regulatory authority of the Center for Devices and Radiological Health.  This program is intended for early stage companies that have not discussed their technology with FDA or participated in the CARE program previously. 

For more information, NCI-funded companies can contact Monique Pond (monique.pond@nih.gov). NHLBI-funded companies should please contact Stephanie Davis (stephanie.davis3@nih.gov).

To learn more about the history of the CARE program, please read our mini review in Clinical and Translational Science. 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “CARE Regulatory Program was originally published by the National Cancer Institute.”

Email